Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis

OBJECTIVE: Patient‐reported outcomes (PROs) provide an opportunity to collect important information relating to patient well‐being, which is often difficult for physicians to measure (e.g., quality of life, pain, fatigue, and sleep). Here we evaluate the effects of certolizumab pegol (CZP) on PROs d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, J., Kivitz, A., van Tubergen, A., Deodhar, A., Coteur, G., Woltering, F., Landewé, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054930/
https://www.ncbi.nlm.nih.gov/pubmed/25832312
http://dx.doi.org/10.1002/acr.22594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054930/
https://www.ncbi.nlm.nih.gov/pubmed/25832312
http://dx.doi.org/10.1002/acr.22594

Ejemplares similares